Date: 2013-07-01
Type of information: Private placement
Company: Galapagos (Belgium)
Investors:
Amount: €584,200.40
Funding type: warrant exercises
Planned used:
Others: * On July 1, 2013, Galapagos has nnounced a capital increase arising from employee and management warrant exercises. Since its inception in 1999, Galapagos has used warrant plans to incentivize personnel and management and have them share in the success of the company. Following warrant exercises during the exercise period running from 8 June 2013 through 21 June 2013, Galapagos issued 90,143 new ordinary shares on 1 July 2013 for a total capital increase (including issuance premium) of €584,200.40.
Galapagos\' Executive Committee has put a warrant exercise program into place whereby Executive Committee members have made a commitment to exercise a fixed number of warrants during subsequent exercise periods, subject to certain conditions. During this exercise period, three Executive Committee members exercised warrants for a combined total of 7,500 warrants. CEO Onno van de Stolpe did not exercise any warrants.
To date, Galapagos\' total share capital amounts to €160,962,030.82; the total number of securities conferring voting rights is 29,755,302, which is also the total number of voting rights (the \"denominator\"), and all securities conferring voting rights and all voting rights are of the same category. The total number of rights (warrants) to subscribe to not yet issued securities conferring voting rights is 3,033,225, which equals the total number of voting rights that may result from the exercise of these warrants.
Therapeutic area:
